A phase II trial of capecitabine and vinorelbine as first-line treatment in patients with metastatic breast cancer (BC)

被引：0
|
作者：
Palumbo, Raffaella [1 ]
Bernardo, Antonio [1 ]
Strada, Maria Rosa [1 ]
Poggi, Guido [1 ]
Delmonte, Angelo [1 ]
Teragni, Cristina [1 ]
Frascaroli, Mara [1 ]
Bernardo, Giovanni [1 ]
机构：
[1] Fdn Maugeri, Pavia, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：75 / 75
页数：1
相关论文
共 50 条
  • [21] Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2+ metastatic breast cancer
    Jahanzeb, M
    Mortimer, JE
    Yunus, F
    Irwin, DH
    Speyer, J
    Koletsky, AJ
    Klein, P
    Sabir, T
    Kronish, L
    ONCOLOGIST, 2002, 7 (05): : 410 - 417
  • [22] A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer
    Finek, Jindrich
    Holubec, Lubos, Jr.
    Svoboda, Tomas
    Sefrhansova, Lucie
    Pavlikova, Ivana
    Votavova, Marie
    Sediva, Marcela
    Filip, Stanislav
    Kozevnikova, Renata
    Kormunda, Stanislav
    ANTICANCER RESEARCH, 2009, 29 (02) : 667 - 670
  • [23] Gemcitabine as first-line therapy in patients with metastatic breast cancer: A phase II trial
    Blackstein, M
    Vogel, CL
    Ambinder, R
    Cowan, J
    Iglesias, J
    Melemed, A
    ONCOLOGY, 2002, 62 (01) : 2 - 8
  • [24] Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer
    Chua, Daniel T. T.
    Yiu, Harry Ho-Yin
    Seetalarom, Kasan
    Ng, Alice Wan-Ying
    Kurnianda, Johan
    Shotelersuk, Kanjana
    Krishnan, Gopala
    Hong, Ruey-Long
    Yang, Muh-Hwa
    Wang, Cheng-Hsu
    Sze, Wing-Kin
    Ng, Wai-Tong
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2012, 34 (09): : 1225 - 1230
  • [25] A PHASE II TRIAL OF ORAL VINORELBINE AND CAPECITABINE IN ANTHRACYCLINE PRETREATED PATIENTS WITH METASTATIC BREAST CANCER
    Finek, J.
    Holubec, L.
    Svoboda, T.
    Sefrhansova, L.
    Pavlikova, I.
    Votavova, M.
    Sediva, M.
    Filip, S.
    Kozevnikova, R.
    Kormunda, S.
    ANTICANCER RESEARCH, 2008, 28 (6B) : 4023 - 4023
  • [26] Capecitabine Combined With Docetaxel Versus Vinorelbine Followed by Capecitabine Maintenance Medication for First-Line Treatment of Patients With Advanced Breast Cancer: Phase 3 Randomized Trial
    Wang, Jiayu
    Xu, Binghe
    Yuan, Peng
    Ma, Fei
    Li, Qing
    Zhang, Pin
    Cai, Ruigang
    Fan, Ying
    Luo, Yang
    Li, Qiao
    CANCER, 2015, 121 (19) : 3412 - 3421
  • [27] First-line treatment of metastatic breast cancer with mitoxantrone, vinorelbine, and carboplatin
    Kakolyris, S
    Kourousis, C
    Koukourakis, M
    Androulakis, N
    Vamvakas, L
    Agelaki, S
    Hatzidaki, D
    Samonis, G
    Tsiftsis, D
    Georgoulias, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06): : 568 - 572
  • [28] Gemcitabine-vinorelbine as first-line treatment for metastatic breast cancer
    Bensalem, A.
    Bouzid, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [29] First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
    E van Meerten
    F A L M Eskens
    E C van Gameren
    L Doorn
    A van der Gaast
    British Journal of Cancer, 2007, 96 : 1348 - 1352
  • [30] Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer
    Chan, Arlene
    Conte, Pier-Franco
    Petruzelka, Lubos
    Tubiana-Mathieu, Nicole
    Ganju, Vinod
    Llombart, Antonio
    Espie, Marc
    Majois, Francoise
    Gil, Miguel Gil
    Vaissiere, Nathalie
    Villanova, Gustavo
    ANTICANCER RESEARCH, 2013, 33 (06) : 2657 - 2664
12345